EURASIA Pharmaceutical FORUM will be held on November 20-21 in Moscow.
The event will give an overview of the recent regulatory developments in the Eurasian Union, discuss the harmonization of national regulations and the implications of recent changes for the regulatory and product approval strategies in the region, as well as facilitate an open dialogue between regulatory officials and the industry. Learn more about the market that unites Russia, Belarus, Kazakhstan, Uzbekistan, Armenia with a combined population of more than 180 million people.
7th International Forum «Clinical Trials in Russia»
150+ professionals involved in the clinical trials of pharmaceutical drugs and medical devices will meet at the 7th international Clinical Trials in Russia Forum on the 13th – 14th November in Moscow. Topical and compact 2-day programme filled with interactive formats, panel discussions and debates, showcasing original viewpoints and innovative studies.
Effective Pharmacovigilance system is the Basis of Safety and Wellbeing of Patients
The first International Conference “PHARMACOVIGILANCE. Challenges and opportunities”, unprecedented in its speakers and content, took place on October 10, 2018 in Moscow. More than 600 experts in the field of drug safety monitoring took part in the Conference. The event was organised by the Federal Service for Surveillance in Healthcare (Roszdravnadzor) and the Association of International Pharmaceutical Manufacturers (AIPM).
Conference «Pharmacovigilance. Challenges and opportunities» 2018
The Federal Service for Surveillance in Healthcare presents its complements to the Council for International Organizations of Medical Sciences and informs that the conference «Pharmacovigilance. Challenges and opportunities» will take place in Moscow on 10 October 2018.
Introducing company interests, on which share it is necessary about 80 % made and sold in the world of pharmaceutical production and the medical equipment, AIPM considers as the priority cooperation with the Russian bodies of public health services, and also with legislative and executive branches of the power, for the purpose of working out of the program of creation of favorable conditions for sale and-or production of the international pharmaceutical companies in territory of the Russian Federation